Population protection by vaccination against infections has been one of the major achievements of public health and is of considerable importance in controlling respiratory disease. “Vaccines are able to protect patients against infections and reduce the number of episodes and complications in particular in patients at risk,” said Dr Rosario Menéndez (University Hospital La Fe, Spain) [1].
Globally, lower respiratory tract infections are the fourth most common cause of death [2]. In Europe, the annual incidence of community-acquired pneumonia has been estimated at 1.07-1.2 cases per 1,000 persons per year. However, in people ≥65 years, this incidence increases to 14 cases per 1,000 persons per year [3]. A systematic review and meta-analysis published this year revealed that the burden of pneumonia requiring hospitalisation among older adults is substantial. Based on data from 52 hospital studies reporting data on pneumonia mortality, the authors estimated that about 1.1 million in-hospital deaths occurred among older adults from 1996 through 2017 [4]. “One important aspect is that viruses facilitate bacterial infections,” said Dr Menéndez. Several mechanisms contribute to this effect, such as epithelial damage, increased capillary permeability, and reduced phagocytosis [5].
Vaccines, such as influenza vaccines, are effective in reducing hospitalisations, both in the general population as well as in chronic obstructive pulmonary disease patients [6,7]. In addition, they can reduce the transmission and control the disease spread, and can counteract antimicrobial resistance through multiple pathways [8]. They reduce both appropriate and inappropriate use of antimicrobials by reducing overall disease incidence, including infections caused by viruses that are often inappropriately treated with antibiotics.
Additional indirect benefits
In addition, influenza and pneumococcal infections increase cardiovascular risk. Although data are not yet consistent, there is a suggested beneficial effect of vaccinations in the prevention of cardiovascular events [9]. By reducing community-acquired pneumonia, vaccinations can prevent the vicious circle in which pneumonia drives unhealthy aging (see Figure). “So, it is our responsibility to contribute to an increasing awareness of vaccination among patients and vaccinators,” concluded Dr Menéndez.
Figure: A vicious cycle of unhealthy aging—the self-amplifying cycle of interactions between pneumonia and comorbidities [10]
- Menéndez R. Oral abstract 3750, ERS 2019, 29 Sept-2 Oct, Madrid, Spain.
- Lozano R, et al. Lancet 2012;380(9859):2095-2128.
- Torres A, et al. Thorax 2013;68(11): 1057-65.
- Shi T, et al. J Infect Dis 2019 Mar 8. pii: jiz053. doi: 10.1093/infdis/jiz053.
- Paget C & Trottein F. Front Immunol 2019;10:336. doi: 10.3389/fimmu.2019.00336.
- Rolfes MA, et al. Clin Infect Dis 2019;69(11):1845-1853.
- Mulpuru S, et al. Chest 2019;155(1):69-78.
- Lipsitch M & Siber GR. MBio 2016;7: pii: e00428-16. Doi: 10.1128/mBio.00428-16.
- Fountoulaki K, et al. Cardiology 2018;141(2):98-106.
- Quinton LJ, et al. Physiol Rev 2018;98(3):1417-1464.
Posted on
Previous Article
« Smart shirt as a device to measure tidal volumes in real-life setting Next Article
Antifibrotic therapy slows disease progression in ILD »
« Smart shirt as a device to measure tidal volumes in real-life setting Next Article
Antifibrotic therapy slows disease progression in ILD »
Table of Contents: ERS 2019
Featured articles
Letter from the Editor
Interview with ERS president Prof. Tobias Welte
Holistic View on Asthma
Holistic view on asthma
COPD Management
COPD patients derive clinical benefit from β-blockers
COPD patients harbouring Pseudomonas Aeruginosa face high risk of hospitalisation
One blood eosinophil count is sufficient to guide ICS therapy
Female COPD patients frequently suffer from anxiety and depression
Dual bronchodilation improves ventilation dynamics in COPD patients
Vaping
Vaping impairs innate immune response of the airway
Alternative nicotine delivery products: no help in smoking cessation
Air Pollution
Pregnant women and their offspring: a high-risk group for air pollution
Taxi drivers exposed to highest levels of black carbon pollution
Infectious Respiratory Disease: the Role of Vaccines
Vaccines show multiple positive effects with respect to respiratory health
Pneumococcal vaccines: an effective way to reduce COPD hospitalisations
Interstitial Lung Disease
Antifibrotic therapy slows disease progression in ILD
Reduction of FVC decline in systemic sclerosis-associated ILD
Registry confirms nintedanib efficacy under real-life conditions
Best of the Posters
Fever during immunotherapy for NSCLC associated with shorter PFS
Smart shirt as a device to measure tidal volumes in real-life setting
Exercise with virtual reality beneficial for COPD patients
NSCLC: A new way to evaluate hilar and mediastinal lymph nodes
COPD patients do not benefit from azithromycin therapy longer than a year
Novel Developments in Infectious Disease
Long-term azithromycin decreases exacerbations in primary ciliary dyskinesia
Predicting community-acquired pneumonia outcomes by microRNA testing
Pulmonary Vascular Disease
Balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension
Related Articles
October 26, 2021
Smartphone app improves BP control independent of age, sex, and BMI
January 29, 2024
Biannual zilebesiran associated with substantial BP reductions
February 3, 2022
The scope of remote healthcare in hypertension and hyperlipidaemia
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com